GLP-1 medications including semaglutide are being studied for their potential role in eating disorder treatment, with emerging evidence suggesting they may reduce binge urges in some patients through their effects on food reward pathways
If you have concerns about gastrointestinal side effects, discuss them with your healthcare team, who can help determine whether symptoms represent expected medication effects requiring management strategies or whether they indicate a need for treatment modification
According to epidemiological data, NAFLD prevalence is highest in the Middle East (31.79%), followed by North America (30.45%), Europe (23.71%), and Africa (13.48%) [12]
Your body mass index (BMI) is 30 or greater, or 27 or greater if you have at least 1 weight-related condition (such as type 2 diabetes, obstructive sleep apnea, hypertension, dyslipidemia, etc.)
This article explains what retatrutide is, why bulk purchasing is unlawful, the significant dangers of sourcing unlicensed medicines, and the safe, regulated alternatives available through the NHS
M.ShawgoT.et al (2020)